Smith+Nephew Records Early Wins in Ortho Turnaround

Smith+Nephew reported 3Q22 orthopedic sales of $849.3 million, -2.2% compared to the third quarter of 2021. Excluding the impact of currency headwinds, the company achieved underlying growth of 2.1% in its orthopedic franchise and 7.1% in sports medicine.

Volume-based procurement (VBP) in China hurt orthopedic sales significantly....

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Mike Evers is a Senior Market Analyst and writer with over 15 years of experience in the medical industry, spanning cardiac rhythm management, ER coding and billing, and orthopedics. He joined ORTHOWORLD in 2018, where he provides market analysis and editorial coverage.

Contact Us